Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024;17(2):311-312.
doi: 10.1016/j.jcmgh.2023.10.011. Epub 2023 Nov 17.

Fatty Acid Esterification as a NASH Therapeutic Target

Affiliations
Editorial

Fatty Acid Esterification as a NASH Therapeutic Target

Ikki Sakuma et al. Cell Mol Gastroenterol Hepatol. 2024.
No abstract available

PubMed Disclaimer

Comment on

  • GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner.
    Smith KR, Wang W, Miller MR, Boucher M, Reynold JE, Daurio NA, Li D, Hirenallur-Shanthappa D, Ahn Y, Beebe DA, Kelly KL, Ross TT, Bence KK, Wan M. Smith KR, et al. Cell Mol Gastroenterol Hepatol. 2024;17(2):279-291. doi: 10.1016/j.jcmgh.2023.10.002. Epub 2023 Oct 14. Cell Mol Gastroenterol Hepatol. 2024. PMID: 37844795 Free PMC article.

References

    1. Wong R.J., Aguilar M., Cheung R., et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–555. - PubMed
    1. Le M.H., Le D.M., Baez T.C., et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023;79:287–295. - PubMed
    1. Zhai M., Liu Z., Long J., et al. The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017. Sci Rep. 2021;11:5195. - PMC - PubMed
    1. Vatner D.F., Majumdar S.K., Kumashiro N., et al. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. Proc Natl Acad Sci U S A. 2015;112:1143–1148. - PMC - PubMed
    1. Neschen S., Morino K., Hammond L.E., et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2005;2:55–65. - PubMed